January 2019—Quest Diagnostics and Oxford Immunotec announced that Quest has completed its acquisition of the U.S. laboratory services business of Oxford Immunotec; the T-Spot.TB tuberculosis and the Accutix tick-borne disease testing services are now part of Quest’s portfolio of infectious disease testing services. As part of the transaction, Oxford Immunotec will sell T-Spot.TB test kits and related accessories to Quest under the terms of a long-term supply agreement. In addition, the parties have entered into a strategic collaboration agreement to drive continued growth of T-Spot.TB testing in the U.S.
Quest and Marin General Hospital have entered into a definitive agreement for Quest to acquire the outreach laboratory services operations of the Greenbrae, Calif.–based hospital. Quest also announced it has acquired certain assets of the outreach laboratory services operation of Hurley Medical Center, located in Flint, Mich.
Quest Diagnostics, 973-520-2700